86 related articles for article (PubMed ID: 9714568)
1. cis-parinaric acid is a ligand for the human peroxisome proliferator activated receptor gamma: development of a novel spectrophotometric assay for the discovery of PPARgamma ligands.
Palmer CN; Wolf CR
FEBS Lett; 1998 Jul; 431(3):476-80. PubMed ID: 9714568
[TBL] [Abstract][Full Text] [Related]
2. Fluorescence-based ligand-binding assays for peroxisome proliferator-activated receptors.
Adamson DJ; Palmer CN
Methods Enzymol; 2002; 357():188-97. PubMed ID: 12424910
[No Abstract] [Full Text] [Related]
3. Ligand selectivity of the peroxisome proliferator-activated receptor alpha.
Lin Q; Ruuska SE; Shaw NS; Dong D; Noy N
Biochemistry; 1999 Jan; 38(1):185-90. PubMed ID: 9890897
[TBL] [Abstract][Full Text] [Related]
4. A novel method for analysis of nuclear receptor function at natural promoters: peroxisome proliferator-activated receptor gamma agonist actions on aP2 gene expression detected using branched DNA messenger RNA quantitation.
Burris TP; Pelton PD; Zhou L; Osborne MC; Cryan E; Demarest KT
Mol Endocrinol; 1999 Mar; 13(3):410-7. PubMed ID: 10076998
[TBL] [Abstract][Full Text] [Related]
5. Peroxisome proliferator-activated receptor gamma activation in human breast cancer.
Yee LD; Sabourin CL; Liu L; Li HM; Smith PJ; Seewaldt V; Kniss DA
Int J Oncol; 1999 Nov; 15(5):967-73. PubMed ID: 10536181
[TBL] [Abstract][Full Text] [Related]
6. p120 acts as a specific coactivator for 9-cis-retinoic acid receptor (RXR) on peroxisome proliferator-activated receptor-gamma/RXR heterodimers.
Monden T; Kishi M; Hosoya T; Satoh T; Wondisford FE; Hollenberg AN; Yamada M; Mori M
Mol Endocrinol; 1999 Oct; 13(10):1695-703. PubMed ID: 10517671
[TBL] [Abstract][Full Text] [Related]
7. Substitution of a conserved amino acid residue alters the ligand binding properties of peroxisome proliferator activated receptors.
Causevic M; Wolf CR; Palmer CN
FEBS Lett; 1999 Dec; 463(3):205-10. PubMed ID: 10606722
[TBL] [Abstract][Full Text] [Related]
8. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma.
Kliewer SA; Sundseth SS; Jones SA; Brown PJ; Wisely GB; Koble CS; Devchand P; Wahli W; Willson TM; Lenhard JM; Lehmann JM
Proc Natl Acad Sci U S A; 1997 Apr; 94(9):4318-23. PubMed ID: 9113987
[TBL] [Abstract][Full Text] [Related]
9. Peroxisome proliferator-activated receptor gamma as a novel target in cancer therapy: binding and activation by an aromatic fatty acid with clinical antitumor activity.
Samid D; Wells M; Greene ME; Shen W; Palmer CN; Thibault A
Clin Cancer Res; 2000 Mar; 6(3):933-41. PubMed ID: 10741718
[TBL] [Abstract][Full Text] [Related]
10. Evidence for direct binding of fatty acids and eicosanoids to human peroxisome proliferators-activated receptor alpha.
Murakami K; Ide T; Suzuki M; Mochizuki T; Kadowaki T
Biochem Biophys Res Commun; 1999 Jul; 260(3):609-13. PubMed ID: 10403814
[TBL] [Abstract][Full Text] [Related]
11. Control of COX-2 gene expression through peroxisome proliferator-activated receptor gamma in human cervical cancer cells.
Han S; Inoue H; Flowers LC; Sidell N
Clin Cancer Res; 2003 Oct; 9(12):4627-35. PubMed ID: 14555539
[TBL] [Abstract][Full Text] [Related]
12. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta.
Forman BM; Chen J; Evans RM
Proc Natl Acad Sci U S A; 1997 Apr; 94(9):4312-7. PubMed ID: 9113986
[TBL] [Abstract][Full Text] [Related]
13. The nuclear receptor PPARgamma - bigger than fat.
Kliewer SA; Willson TM
Curr Opin Genet Dev; 1998 Oct; 8(5):576-81. PubMed ID: 9794815
[TBL] [Abstract][Full Text] [Related]
14. Expression of peroxisome proliferator-activated receptor gamma (PPARgamma) in human transitional bladder cancer and its role in inducing cell death.
Guan YF; Zhang YH; Breyer RM; Davis L; Breyer MD
Neoplasia; 1999 Oct; 1(4):330-9. PubMed ID: 10935488
[TBL] [Abstract][Full Text] [Related]
15. Fatty-acyl-CoA thioesters inhibit recruitment of steroid receptor co-activator 1 to alpha and gamma isoforms of peroxisome-proliferator-activated receptors by competing with agonists.
Murakami K; Ide T; Nakazawa T; Okazaki T; Mochizuki T; Kadowaki T
Biochem J; 2001 Jan; 353(Pt 2):231-8. PubMed ID: 11139385
[TBL] [Abstract][Full Text] [Related]
16. Binding of prostaglandins to human PPARgamma: tool assessment and new natural ligands.
Ferry G; Bruneau V; Beauverger P; Goussard M; Rodriguez M; Lamamy V; Dromaint S; Canet E; Galizzi JP; Boutin JA
Eur J Pharmacol; 2001 Apr; 417(1-2):77-89. PubMed ID: 11301062
[TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferator-activated receptor-gamma: a versatile metabolic regulator.
Rocchi S; Auwerx J
Ann Med; 1999 Oct; 31(5):342-51. PubMed ID: 10574507
[TBL] [Abstract][Full Text] [Related]
18. Expression of peroxisome proliferator-activated receptor gamma (PPARgamma) in rat aortic smooth muscle cells.
Iijima K; Yoshizumi M; Ako J; Eto M; Kim S; Hashimoto M; Sugimoto N; Liang YQ; Sudoh N; Toba K; Ouchi Y
Biochem Biophys Res Commun; 1998 Jun; 247(2):353-6. PubMed ID: 9642130
[TBL] [Abstract][Full Text] [Related]
19. Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay.
Krey G; Braissant O; L'Horset F; Kalkhoven E; Perroud M; Parker MG; Wahli W
Mol Endocrinol; 1997 Jun; 11(6):779-91. PubMed ID: 9171241
[TBL] [Abstract][Full Text] [Related]
20. Expression of peroxisome proliferator-activated receptor gamma and the growth inhibitory effect of its synthetic ligands in human salivary gland cancer cell lines.
Begum NM; Nakashiro K; Kawamata H; Uchida D; Shintani S; Ikawa Y; Sato M; Hamakawa H
Int J Oncol; 2002 Mar; 20(3):599-605. PubMed ID: 11836575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
